Mast cells promote lung vascular remodelling in pulmonary hypertension

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Respiratory Journal

• Publication date

  2010-12-09

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1183/09031936.00043310PMID 21148228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lung Endothelial Dysfunction in Congestive Heart Failure: Role of Impaired Ca2+ Signaling and Cytoskeletal Reorganization

  2010cited by this paper
• Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice

  2009cited by this paper
• Updated clinical classification of pulmonary hypertension.

  2009cited by this paper
• Serotonin and pulmonary hypertension--from bench to bedside?

  2009cited by this paper
• Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease*

  2009influential reference
• Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

  2009cited by this paper
• The tyrosine kinase network regulating mast cell activation

  2009cited by this paper
• Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.

  2009influential reference
• In vitro hypoxia increases production of matrix metalloproteinases and tryptase in isolated rat lung mast cells.

  2008cited by this paper
• Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling

  2008cited by this paper
• Prevention of Mast Cell Degranulation by Disodium Cromoglycate Attenuates the Development of Hypoxic Pulmonary Hypertension in Rats Exposed to Chronic Hypoxia

  2008cited by this paper
• A quantitative analysis of kinase inhibitor selectivity

  2008cited by this paper
• Inhalation of the Phosphodiesterase-3 Inhibitor Milrinone Attenuates Pulmonary Hypertension in a Rat Model of Congestive Heart Failure

  2007cited by this paper
• Role of mast cells in airway remodeling.

  2007cited by this paper
• Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.

  2006cited by this paper
• A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2*

  2005cited by this paper
• Reversal of experimental pulmonary hypertension by PDGF inhibition.

  2005cited by this paper
• Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure

  2005cited by this paper
• KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation

  2005cited by this paper
• Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells.

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• A Model-Based Background Adjustment for Oligonucleotide Expression Arrays

  2004cited by this paper
• Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells.

  2003cited by this paper
• Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure.

  2001cited by this paper
• Airway Smooth Muscle Cells

  1998cited by this paper
• Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

  1995cited by this paper
• Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus.

  1991cited by this paper
• Mechanism of ketotifen action in hypersensitivity reactions. Its effect on cellular enzymatic activities.

  1991cited by this paper
• Lung mast cells in plexogenic pulmonary arteriopathy.

  1991cited by this paper
• Mast cell granules cause proliferation of human microvascular endothelial cells.

  1986cited by this paper
• Hypoxic pulmonary hypertension in the mast cell-deficient mouse.

  1983cited by this paper
• Effects of cyproheptadine, ketotifen and sodium nitroprusside on mechanical activity and calcium uptake in guinea pig taenia coli in vitro.

  1980cited by this paper
• Lung mast cell density and distribution in chronically hypoxic animals.

  1977cited by this paper
• Lung mast cell hyperplasia and pulmonary histamine-forming capacity in hypoxic rats.

  1974cited by this paper
• Pulmonary mast cells in mitral stenosis.

  1969cited by this paper

• Remodelling of the endothelial extracellular matrix promotes smooth muscle cell hyperplasia in pulmonary hypertension due to left heart disease.

  2025cites this paper
• Identification of pulmonary artery stiffening due to left heart disease by ultrasonography.

  2025cites this paper
• Treg Cells Attenuate Pulmonary Venous Remodeling in PH-LHD via NLRC3 Signaling

  2025cites this paper
• Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management

  2024cites this paper
• RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease

  2024cites this paper
• Key Genes and Biological Pathways in Pulmonary Arterial Hypertension Related to Endoplasmic Reticulum Stress Identified by Bioinformatics

  2024cites this paper
• Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle

  2024cites this paper
• B-cells in pulmonary arterial hypertension: friend, foe or bystander?

  2024cites this paper
• Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension

  2024cites this paper
• The role of serum sodium in poor prognosis evaluation of pulmonary hypertension associated with left heart disease.

  2024cites this paper
• Indigo Leaves-Induced Pulmonary Arterial Remodeling without Right Ventricular Hypertrophy in Rats.

  2024cites this paper
• The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets.

  2023cites this paper
• Elastin stabilization prevents impaired biomechanics in human pulmonary arteries and pulmonary hypertension in rats with left heart disease

  2023cites this paper
• Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease

  2023cites this paper
• Pathophysiological Involvement of Mast Cells and the Lipid Mediators in Pulmonary Vascular Remodeling

  2023cites this paper
• Pulmonary vascular fibrosis in pulmonary hypertension - The role of the extracellular matrix as a therapeutic target.

  2023cites this paper
• Immune Cells in Pulmonary Arterial Hypertension.

  2022cites this paper
• Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer

  2022cites this paper
• Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension

  2022cites this paper
• The Pathobiology of Pulmonary Arterial Hypertension.

  2022cites this paper
• Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening

  2022cites this paper
• Uncovering the Mast Cell Response to Mycobacterium tuberculosis

  2022cites this paper
• Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodeling

  2022cites this paper
• Immunity and Inflammation in Pulmonary Arterial Hypertension: From Pathophysiology Mechanisms to Treatment Perspective.

  2022cites this paper
• Inhibition of immunoglobulin E attenuates pulmonary hypertension

  2021cites this paper
• Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

  2021cites this paper
• Significance of Mast Cell Formed Extracellular Traps in Microbial Defense

  2021cites this paper
• Bioinformatic exploration of the immune related molecular mechanism underlying pulmonary arterial hypertension

  2021cites this paper
• The roles of immune system and autoimmunity in pulmonary arterial hypertension: A Review.

  2021cites this paper
• Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective

  2020cites this paper
• Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice

  2020cites this paper
• Rare Pulmonary Connective Tissue Type Mast Cells Regulate Lung Endothelial Cell Angiogenesis.

  2020cites this paper
• Perivascular Inflammation in Pulmonary Arterial Hypertension

  2020cites this paper
• The Biological Bases of Group 2 Pulmonary Hypertension

  2019cites this paper
• NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension

  2019cites this paper
• Revealing the pathogenic changes of PAH based on multiomics characteristics

  2019cites this paper
• c-Kit deficiency impairs nitric oxide signaling in smooth muscle cells.

  2019cites this paper
• Prodrug approaches to reduce treprostinil toxicity

  2019cites this paper
• Hypoxic mast cells accelerate the proliferation, collagen accumulation and phenotypic alteration of human lung fibroblasts

  2019cites this paper
• Optimising experimental research in respiratory diseases: an ERS statement

  2018cites this paper
• The Role of the Human Immune System in Chronic Hypoxic Pulmonary Hypertension

  2018cites this paper
• Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series)

  2018cites this paper
• The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension

  2018cites this paper
• STVNa attenuates right ventricle hypertrophy and pulmonary artery remodeling in rats induced by transverse aortic constriction.

  2018cites this paper
• New dynamic viewing of mast cells in pulmonary arterial hypertension (PAH): contributors or outsiders to cardiovascular remodeling.

  2018cites this paper
• The Role of Mast Cells in the Pathophysiology of Pulmonary Fibrosis

  2018cites this paper
• Four-day pulse of sodium cromoglycate modulates pulmonary vessel wall remodeling during 21-day hypoxia in rats

  2018cites this paper
• Immune cells and autoantibodies in pulmonary arterial hypertension

  2017cites this paper
• Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension

  2017cites this paper
• Mini-review: The role of mast cells in pulmonary hypertension

  2017cites this paper
• The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension.

  2017cites this paper
• Lung Circulation.

  2016cites this paper
• Adhesion Molecules: Master Controllers of the Circulatory System.

  2016cites this paper
• Mast cells and their activation in lung disease.

  2016cites this paper
• The Effects of Chronic Hypoxia on Inflammation and Pulmonary Vascular Function

  2016cites this paper
• Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension

  2016cites this paper
• Update on novel targets and potential treatment avenues in pulmonary hypertension.

  2016cites this paper
• The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

  2015cites this paper
• CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction

  2015cites this paper
• The pathophysiology of pulmonary hypertension in left heart disease.

  2015cites this paper
• Dose-Dependent, Therapeutic Potential of Angiotensin-(1–7) for the Treatment of Pulmonary Arterial Hypertension

  2015cites this paper
• Title: The Role of Inflammation in Hypoxic Pulmonary Hypertension: from cellular mechanisms

  2014cites this paper
• A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiology

  2014cites this paper
• Immunopathological aspects of schistosomiasis-associated pulmonary arterial hypertension.

  2014cites this paper
• Die pulmonal arterielle Hypertonie - auch eine Erkrankung des Immunsystems? Pulmonary arterial hypertension - a disease of the immune system?

  2014cites this paper
• Die pulmonal arterielle Hypertonie – auch eine Erkrankung des Immunsystems?

  2014cites this paper
• Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.

  2013cites this paper
• Angiotensin-(1–7) Protects From Experimental Acute Lung Injury

  2013cites this paper
• Modification of Hemodynamic and Immune Responses to Exposure with a Weak Antigen by the Expression of a Hypomorphic BMPR2 Gene

  2013cites this paper
• Innovation thérapeutique dans la dysfonction endothéliale associée à l'hypertension artérielle pulmonaire

  2012cites this paper
• PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension

  2012cites this paper
• Mast cells: an expanding pathophysiological role from allergy to other disorders

  2012cites this paper
• Mast cell number, phenotype, and function in human pulmonary arterial hypertension

  2012cites this paper
• Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension.

  2012cites this paper
• Pulmonary hypertension: chapters of innovation and tribulation.

  2012cites this paper
• Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction.

  2012cites this paper
• Animal models of pulmonary hypertension: Rho kinase inhibition.

  2012cites this paper
• Hypoxic pulmonary vasoconstriction requires endothelial signal conduction via connexin 40

  2012cites this paper
• Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension).

  2012cites this paper
• Lung mast cells and hypoxic pulmonary hypertension.

  2012cites this paper
• Quantitative Echokardiographie bei Patienten im Endstadium der chronischen Herzinsuffizienz bei Implantation eines mechanischen ventrikulären Unterstützungssystems

  2012cites this paper
• Mast cells: bridging the gap between pre- and post-capillary pulmonary hypertension?

  2011cites this paper
• Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats

  2011cites this paper
• 1 Lung Mast Cells and Hypoxic Pulmonary Hypertension

  2011cites this paper
• Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension

  2011cites this paper
• Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis

  2011cites this paper